BIOTRON LIMITED - Announcements

Market Cap $17.14M Add to my watchlist

Healthcare Biotechnology

Biotron Limited is an Australia-based biotechnology company. The Company is primarily... Biotron Limited is an Australia-based biotechnology company. The Company is primarily engaged in the funding and management of intermediate and applied biotechnology research and development projects. The Company’s clinical programs include BIT225-001, BIT225-003, BIT225-004, BIT225-005, BIT225-006, BIT225-007 and BIT225-008. BIT225 is in mid-stage clinical development for treatment of HIV-1 and Hepatitis C virus (HCV) infections, with seven clinical trials completed. BIT225 is a HIV-1 Vpu protein inhibitor with the aim of inhibiting virus replication in cellular reservoirs. BIT225 is a viral assembly inhibitor that targets HCV p7 protein. In addition to the development of BIT225, the Company has a portfolio of preclinical antiviral programs developing drugs targeting a range of significant established and emerging viral diseases such as Dengue, Zika and Influenza virus.More

Announcements

Filter Results

All Price Sensitive Only

BIT	Quarterly Activities Report	PRICE SENSITIVE	30/07/21	141.42KB	Share
BIT	Quarterly Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/07/21	155.38KB	Share
BIT	Letter to Shareholders		08/07/21	244.22KB	Share
BIT	Notification of cessation of securities - BIT		01/07/21	21.59KB	Share
BIT	$1.4M R&D Tax Rebate	PRICE SENSITIVE	29/04/21	117.13KB	Share
BIT	Quarterly Activities Report	PRICE SENSITIVE	28/04/21	140.53KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	28/04/21	155.05KB	Share
BIT	Lead Series for SARS-COV-2 Program		11/03/21	107.54KB	Share
BIT	Half Yearly Report and Accounts	PRICE SENSITIVE	23/02/21	447.04KB	Share
BIT	Quarterly Activities Report	PRICE SENSITIVE	29/01/21	141.92KB	Share
BIT	Quarterly Cashflow Report	PRICE SENSITIVE	29/01/21	155.26KB	Share
BIT	Results of Meeting		19/11/20	157.7KB	Share
BIT	Presentation to Annual General Meeting		19/11/20	373.06KB	Share
BIT	Quarterly Activities Report	PRICE SENSITIVE	29/10/20	143.32KB	Share
BIT	Quarterly Cashflow Report	PRICE SENSITIVE	29/10/20	155.86KB	Share
BIT	BIT225 HIV-1 Immunomodulatory Paper Published		15/10/20	119.59KB	Share
BIT	Presentation to Investors		14/10/20	518.47KB	Share
BIT	Annual Report and Notice of Annual General Meeting		09/10/20	8.31MB	Share
BIT	Biotron Compounds Show Activity Against SARS-CoV-2 Virus	PRICE SENSITIVE	07/09/20	141.9KB	Share
BIT	Trading Halt	PRICE SENSITIVE	03/09/20	114.48KB	Share
BIT	Pause in Trading	PRICE SENSITIVE	03/09/20	115.52KB	Share
BIT	Full Year Statutory Accounts	PRICE SENSITIVE	27/08/20	677.29KB	Share
BIT	Appendix 4G and Corporate Governance Statement		27/08/20	392.94KB	Share
BIT	Quarterly Activities Report	PRICE SENSITIVE	29/07/20	141.46KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	29/07/20	155.99KB	Share
BIT	Letter to Shareholders		22/07/20	282.84KB	Share
BIT	Appointment of Chief Medical Officer		17/07/20	83.83KB	Share
BIT	BIT225 Reverses HIV-Induced Immune Evasion	PRICE SENSITIVE	06/07/20	669.54KB	Share
BIT	Latest BIT225data presented at International Aids Conference		22/06/20	100.6KB	Share
BIT	Quarterly Activities Report	PRICE SENSITIVE	23/04/20	144.47KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	23/04/20	164.52KB	Share
BIT	R&D Tax Refund Received	PRICE SENSITIVE	19/03/20	111.09KB	Share
BIT	BIT225 RESTORES IMMUNE FUNCTION IN HIV-1 INFECTIONS	PRICE SENSITIVE	12/03/20	747.75KB	Share
BIT	Half Yearly Report and Accounts	PRICE SENSITIVE	27/02/20	1.73MB	Share
BIT	Letter to Shareholders		25/02/20	250.08KB	Share
BIT	Biotron to Test its Compounds Against Coronavirus	PRICE SENSITIVE	06/02/20	226.09KB	Share
BIT	Appendix 3B		31/01/20	654.69KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	24/01/20	702.24KB	Share
BIT	Response to ASX Price Query	PRICE SENSITIVE	23/01/20	620.57KB	Share
BIT	Change of Director's Interest Notice		22/01/20	552.35KB	Share
BIT	Change of Director's Interest Notice		13/01/20	551.79KB	Share
BIT	Appendix 3B and Appendix 3Y		23/12/19	213.19KB	Share
BIT	Appendix 2A		23/12/19	169.96KB	Share
BIT	Appendix 2A		17/12/19	423.45KB	Share
BIT	Appendix 2A		11/12/19	169.86KB	Share
BIT	Change of Director's Interest Notice		10/12/19	173.54KB	Share
BIT	Change of Director's Interest Notice		05/12/19	641.06KB	Share
BIT	Appendix 2A		05/12/19	490.67KB	Share
BIT	Presentation of HIV Data to CROI and New Patents		03/12/19	100.78KB	Share
BIT	Appendix 3B		28/11/19	983.36KB	Share
BIT	Results of Meeting		26/11/19	332.31KB	Share
BIT	AGM Presentation		26/11/19	1.85MB	Share
BIT	Appendix 3B		21/11/19	984.03KB	Share
BIT	Option Expiry Notice		13/11/19	680.53KB	Share
BIT	Biotron Secures $5.1 Million Underwriting Agreement	PRICE SENSITIVE	08/11/19	228.04KB	Share
BIT	Change of Director's Interest Notice		07/11/19	639.96KB	Share
BIT	Appendix 3B		07/11/19	984.89KB	Share
BIT	Appendix 3B		01/11/19	1.32MB	Share
BIT	Presentation to Investors	PRICE SENSITIVE	31/10/19	980.29KB	Share
BIT	Annual Report and Notice of AGM		24/10/19	2.84MB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	21/10/19	702.34KB	Share
BIT	Appendix 3B		08/10/19	1.31MB	Share
BIT	Appointment of International Advisory Board for BIT225	PRICE SENSITIVE	01/10/19	125.89KB	Share
BIT	Appendix 3B		19/09/19	1.31MB	Share
BIT	Appendix 4G and Corporate Governance Statement		29/08/19	495.01KB	Share
BIT	Full Year Statutory Accounts	PRICE SENSITIVE	29/08/19	1.08MB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	30/07/19	702.33KB	Share
BIT	Letter to Shareholders		11/07/19	242.45KB	Share
BIT	Appendix 3B		19/06/19	1.31MB	Share
BIT	Presentation at BIO 2019	PRICE SENSITIVE	07/06/19	6.64MB	Share
BIT	Appendix 3B		07/05/19	983.88KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	11/04/19	705.54KB	Share
BIT	Appendix 3B		11/04/19	991.17KB	Share
BIT	Appendix 3B		28/03/19	991.14KB	Share
BIT	Half Yearly Report and Accounts	PRICE SENSITIVE	20/02/19	1.72MB	Share
BIT	Appendix 3B		12/02/19	993.46KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	18/01/19	690.62KB	Share
BIT	Appendix 3B		17/01/19	993.53KB	Share
BIT	Appendix 3B		07/01/19	994.15KB	Share
BIT	Appendix 3B		14/12/18	993.58KB	Share
BIT	Letter to Shareholders		12/12/18	207.28KB	Share
BIT	Exercise of Options Raises $4.7 Million		05/12/18	141.11KB	Share
BIT	Appendix 3B		30/11/18	993.21KB	Share
BIT	PRESENTATION OF BIT225-009 HIV-1 PHASE 2 DATA	PRICE SENSITIVE	28/11/18	2.91MB	Share
BIT	Change of Director's Interest Notice		23/11/18	634.21KB	Share
BIT	Appendix 3B		23/11/18	992.45KB	Share
BIT	Change of Principal Place of Business		22/11/18	222.28KB	Share
BIT	Re-Appointment of a Director		20/11/18	28.48KB	Share
BIT	Results of Meeting		20/11/18	315.44KB	Share
BIT	AGM Presentation		20/11/18	1020.79KB	Share
BIT	Appendix 3B		16/11/18	993.33KB	Share
BIT	Presentation of BIT225-009 HIV-1 Phase 2 Data		13/11/18	29.17KB	Share
BIT	Change of Director's Interest Notice		09/11/18	648.49KB	Share
BIT	Appendix 3B		09/11/18	994.12KB	Share
BIT	Change of Director's Interest Notice		02/11/18	662.66KB	Share
BIT	Appendix 3B		02/11/18	994.12KB	Share
BIT	Response to ASX aware letter	PRICE SENSITIVE	30/10/18	614.87KB	Share
BIT	Option Expiry Notice		29/10/18	538.62KB	Share
BIT	Appendix 3B		29/10/18	994.35KB	Share
BIT	Change of Director's Interest Notice		25/10/18	679.07KB	Share

BIT Quarterly Activities Report
30/07/21	PRICE SENSITIVE	141.42KB	Share
BIT Quarterly Appendix 4C Cash Flow Report
30/07/21	PRICE SENSITIVE	155.38KB	Share
BIT Letter to Shareholders
08/07/21		244.22KB	Share
BIT Notification of cessation of securities - BIT
01/07/21		21.59KB	Share
BIT $1.4M R&D Tax Rebate
29/04/21	PRICE SENSITIVE	117.13KB	Share
BIT Quarterly Activities Report
28/04/21	PRICE SENSITIVE	140.53KB	Share
BIT Appendix 4C - quarterly
28/04/21	PRICE SENSITIVE	155.05KB	Share
BIT Lead Series for SARS-COV-2 Program
11/03/21		107.54KB	Share
BIT Half Yearly Report and Accounts
23/02/21	PRICE SENSITIVE	447.04KB	Share
BIT Quarterly Activities Report
29/01/21	PRICE SENSITIVE	141.92KB	Share
BIT Quarterly Cashflow Report
29/01/21	PRICE SENSITIVE	155.26KB	Share
BIT Results of Meeting
19/11/20		157.7KB	Share
BIT Presentation to Annual General Meeting
19/11/20		373.06KB	Share
BIT Quarterly Activities Report
29/10/20	PRICE SENSITIVE	143.32KB	Share
BIT Quarterly Cashflow Report
29/10/20	PRICE SENSITIVE	155.86KB	Share
BIT BIT225 HIV-1 Immunomodulatory Paper Published
15/10/20		119.59KB	Share
BIT Presentation to Investors
14/10/20		518.47KB	Share
BIT Annual Report and Notice of Annual General Meeting
09/10/20		8.31MB	Share
BIT Biotron Compounds Show Activity Against SARS-CoV-2 Virus
07/09/20	PRICE SENSITIVE	141.9KB	Share
BIT Trading Halt
03/09/20	PRICE SENSITIVE	114.48KB	Share
BIT Pause in Trading
03/09/20	PRICE SENSITIVE	115.52KB	Share
BIT Full Year Statutory Accounts
27/08/20	PRICE SENSITIVE	677.29KB	Share
BIT Appendix 4G and Corporate Governance Statement
27/08/20		392.94KB	Share
BIT Quarterly Activities Report
29/07/20	PRICE SENSITIVE	141.46KB	Share
BIT Appendix 4C - quarterly
29/07/20	PRICE SENSITIVE	155.99KB	Share
BIT Letter to Shareholders
22/07/20		282.84KB	Share
BIT Appointment of Chief Medical Officer
17/07/20		83.83KB	Share
BIT BIT225 Reverses HIV-Induced Immune Evasion
06/07/20	PRICE SENSITIVE	669.54KB	Share
BIT Latest BIT225data presented at International Aids Conference
22/06/20		100.6KB	Share
BIT Quarterly Activities Report
23/04/20	PRICE SENSITIVE	144.47KB	Share
BIT Appendix 4C - quarterly
23/04/20	PRICE SENSITIVE	164.52KB	Share
BIT R&D Tax Refund Received
19/03/20	PRICE SENSITIVE	111.09KB	Share
BIT BIT225 RESTORES IMMUNE FUNCTION IN HIV-1 INFECTIONS
12/03/20	PRICE SENSITIVE	747.75KB	Share
BIT Half Yearly Report and Accounts
27/02/20	PRICE SENSITIVE	1.73MB	Share
BIT Letter to Shareholders
25/02/20		250.08KB	Share
BIT Biotron to Test its Compounds Against Coronavirus
06/02/20	PRICE SENSITIVE	226.09KB	Share
BIT Appendix 3B
31/01/20		654.69KB	Share
BIT Appendix 4C - quarterly
24/01/20	PRICE SENSITIVE	702.24KB	Share
BIT Response to ASX Price Query
23/01/20	PRICE SENSITIVE	620.57KB	Share
BIT Change of Director's Interest Notice
22/01/20		552.35KB	Share
BIT Change of Director's Interest Notice
13/01/20		551.79KB	Share
BIT Appendix 3B and Appendix 3Y
23/12/19		213.19KB	Share
BIT Appendix 2A
23/12/19		169.96KB	Share
BIT Appendix 2A
17/12/19		423.45KB	Share
BIT Appendix 2A
11/12/19		169.86KB	Share
BIT Change of Director's Interest Notice
10/12/19		173.54KB	Share
BIT Change of Director's Interest Notice
05/12/19		641.06KB	Share
BIT Appendix 2A
05/12/19		490.67KB	Share
BIT Presentation of HIV Data to CROI and New Patents
03/12/19		100.78KB	Share
BIT Appendix 3B
28/11/19		983.36KB	Share
BIT Results of Meeting
26/11/19		332.31KB	Share
BIT AGM Presentation
26/11/19		1.85MB	Share
BIT Appendix 3B
21/11/19		984.03KB	Share
BIT Option Expiry Notice
13/11/19		680.53KB	Share
BIT Biotron Secures $5.1 Million Underwriting Agreement
08/11/19	PRICE SENSITIVE	228.04KB	Share
BIT Change of Director's Interest Notice
07/11/19		639.96KB	Share
BIT Appendix 3B
07/11/19		984.89KB	Share
BIT Appendix 3B
01/11/19		1.32MB	Share
BIT Presentation to Investors
31/10/19	PRICE SENSITIVE	980.29KB	Share
BIT Annual Report and Notice of AGM
24/10/19		2.84MB	Share
BIT Appendix 4C - quarterly
21/10/19	PRICE SENSITIVE	702.34KB	Share
BIT Appendix 3B
08/10/19		1.31MB	Share
BIT Appointment of International Advisory Board for BIT225
01/10/19	PRICE SENSITIVE	125.89KB	Share
BIT Appendix 3B
19/09/19		1.31MB	Share
BIT Appendix 4G and Corporate Governance Statement
29/08/19		495.01KB	Share
BIT Full Year Statutory Accounts
29/08/19	PRICE SENSITIVE	1.08MB	Share
BIT Appendix 4C - quarterly
30/07/19	PRICE SENSITIVE	702.33KB	Share
BIT Letter to Shareholders
11/07/19		242.45KB	Share
BIT Appendix 3B
19/06/19		1.31MB	Share
BIT Presentation at BIO 2019
07/06/19	PRICE SENSITIVE	6.64MB	Share
BIT Appendix 3B
07/05/19		983.88KB	Share
BIT Appendix 4C - quarterly
11/04/19	PRICE SENSITIVE	705.54KB	Share
BIT Appendix 3B
11/04/19		991.17KB	Share
BIT Appendix 3B
28/03/19		991.14KB	Share
BIT Half Yearly Report and Accounts
20/02/19	PRICE SENSITIVE	1.72MB	Share
BIT Appendix 3B
12/02/19		993.46KB	Share
BIT Appendix 4C - quarterly
18/01/19	PRICE SENSITIVE	690.62KB	Share
BIT Appendix 3B
17/01/19		993.53KB	Share
BIT Appendix 3B
07/01/19		994.15KB	Share
BIT Appendix 3B
14/12/18		993.58KB	Share
BIT Letter to Shareholders
12/12/18		207.28KB	Share
BIT Exercise of Options Raises $4.7 Million
05/12/18		141.11KB	Share
BIT Appendix 3B
30/11/18		993.21KB	Share
BIT PRESENTATION OF BIT225-009 HIV-1 PHASE 2 DATA
28/11/18	PRICE SENSITIVE	2.91MB	Share
BIT Change of Director's Interest Notice
23/11/18		634.21KB	Share
BIT Appendix 3B
23/11/18		992.45KB	Share
BIT Change of Principal Place of Business
22/11/18		222.28KB	Share
BIT Re-Appointment of a Director
20/11/18		28.48KB	Share
BIT Results of Meeting
20/11/18		315.44KB	Share
BIT AGM Presentation
20/11/18		1020.79KB	Share
BIT Appendix 3B
16/11/18		993.33KB	Share
BIT Presentation of BIT225-009 HIV-1 Phase 2 Data
13/11/18		29.17KB	Share
BIT Change of Director's Interest Notice
09/11/18		648.49KB	Share
BIT Appendix 3B
09/11/18		994.12KB	Share
BIT Change of Director's Interest Notice
02/11/18		662.66KB	Share
BIT Appendix 3B
02/11/18		994.12KB	Share
BIT Response to ASX aware letter
30/10/18	PRICE SENSITIVE	614.87KB	Share
BIT Option Expiry Notice
29/10/18		538.62KB	Share
BIT Appendix 3B
29/10/18		994.35KB	Share
BIT Change of Director's Interest Notice
25/10/18		679.07KB	Share

REFRESH

First 2 3 4 5

(20min delay)
Last 1.9¢		Change 0.000(0.00%)		Mkt cap ! $17.14M

Open	High	Low	Value	Volume
2.0¢	2.0¢	1.9¢	$3.921K	205.5K

Buyers (Bids)

No.	Vol.	Price($)
3	776274	1.9¢

Sellers (Offers)

Price($)	Vol.	No.
2.0¢	1861030	4

View Market Depth

No.	Vol.	Price($)
3	923643	0.019
10	1774771	0.018
8	927388	0.017
12	3734154	0.016
10	1205000	0.015

Price($)	Vol.	No.
0.019	53409	1
0.020	1861030	4
0.021	605263	2
0.022	997769	4
0.023	1449422	4

Last trade - 16.10pm 01/10/2024 (20 minute delay)


Last 2.0¢		Change 0.000 ( 2.63 %)
Open	High	Low	Volume
2.0¢	2.0¢	1.9¢	385004
Last updated 13.23pm 01/10/2024 ?

BIT (ASX) Chart

BIOTRON LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories